Researchers reduced 4D-MRI image reconstruction times to 60 seconds More: High-performance computing could improve therapy for hard-to-treat cancer Source: News
read moreSarepta’s Elevidys fails on primary endpoint, but executives see path to wider DMD approval anyway esagonowsky Mon, 10/30/2023 – 16:29 More: Sarepta's Elevidys fails on primary endpoint, but executives see path to wider DMD approval anyway Source: fierce
read moreAragen to beef up biologics manufacturing, investing $30M in new site in India kdunleavy Mon, 10/30/2023 – 14:25 More: Aragen to beef up biologics manufacturing, investing M in new site in India Source: fierce
read moreEli Lilly, Redwire head to space to explore next frontier of drug development fkansteiner Mon, 10/30/2023 – 14:12 More: Eli Lilly, Redwire head to space to explore next frontier of drug development Source: fierce
read moreCoherus rejects ‘heavily discounted’ pricing on Loqtorzi, the first China-made PD-1 drug to win FDA nod aliu Mon, 10/30/2023 – 11:17 More: Coherus rejects 'heavily discounted' pricing on Loqtorzi, the first China-made PD-1 drug to win FDA nod Source: fierce
read moreBluebird inks deal to sell its next FDA priority review voucher to Novartis for $103M zbecker Mon, 10/30/2023 – 11:16 More: Bluebird inks deal to sell its next FDA priority review voucher to Novartis for 3M Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals